Related Experiment Video
Updated: Jul 9, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Deciphering tumor-infiltrating dendritic cells in the single-cell era
Qingyu Huang1, Fuhao Wang1, Di Hao2
1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
Single-cell sequencing reveals diverse dendritic cell (DC) subtypes within tumors. Understanding these DC populations is key to developing new cancer immunotherapies and biomarkers.
Area of Science:
- Immunology
- Oncology
- Genomics
Background:
- Dendritic cells (DCs) are crucial for linking innate and adaptive immunity by processing tumor antigens and activating T cells.
- The tumor microenvironment (TME) contains diverse DC populations that influence anti-tumor responses.
- Single-cell sequencing has enabled high-resolution characterization of this DC heterogeneity.
Purpose of the Study:
- To review current knowledge on DC subtypes within the TME.
- To summarize findings from single-cell studies across various human tumors.
- To highlight the roles of distinct DC subsets in tumor immunity and their potential as biomarkers and therapeutic targets.
Main Methods:
- Comprehensive literature review of single-cell sequencing studies in human tumors.
- Focus on categorization, functions, and interactions of DC subsets.
- Analysis of DC roles in orchestrating tumor-related immune responses.
Main Results:
- Single-cell sequencing has uncovered significant heterogeneity within DC populations in the TME.
- Distinct DC subsets exhibit varied functional capabilities and interactions within the tumor milieu.
- These findings provide insights into the complex immune dynamics within tumors.
Conclusions:
- Understanding DC heterogeneity in the TME is vital for advancing cancer immunology.
- DC subtypes represent potential predictive biomarkers for immunotherapy response.
- Targeting specific DC populations may lead to more effective cancer immunotherapies.
More Related Videos
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021